nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXA2R—endothelium—focal segmental glomerulosclerosis	0.268	0.718	CbGeAlD
Ridogrel—TBXA2R—cortex of kidney—focal segmental glomerulosclerosis	0.105	0.282	CbGeAlD
Ridogrel—TBXA2R—Thromboxane signalling through TP receptor—GNAQ—focal segmental glomerulosclerosis	0.0683	0.109	CbGpPWpGaD
Ridogrel—TBXA2R—Signal amplification—GNAQ—focal segmental glomerulosclerosis	0.0538	0.0859	CbGpPWpGaD
Ridogrel—TBXAS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.053	0.0845	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—GNAQ—focal segmental glomerulosclerosis	0.0335	0.0535	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.0279	0.0445	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.0153	0.0244	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.0144	0.0229	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.0137	0.0218	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.0134	0.0213	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.0128	0.0204	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0117	0.0187	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.0117	0.0186	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.0114	0.0182	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.0112	0.0178	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.0105	0.0167	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.0101	0.0161	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00991	0.0158	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00962	0.0153	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00904	0.0144	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00886	0.0141	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00823	0.0131	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.008	0.0128	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00774	0.0123	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00767	0.0122	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00736	0.0117	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00704	0.0112	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00689	0.011	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.00665	0.0106	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00656	0.0105	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00589	0.0094	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00576	0.00919	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00553	0.00883	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00552	0.00881	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00545	0.00869	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.005	0.00797	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00488	0.00779	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00436	0.00695	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00433	0.00691	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00418	0.00666	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00415	0.00662	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00409	0.00653	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00396	0.00631	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00393	0.00628	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00376	0.006	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00364	0.00581	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00356	0.00568	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00349	0.00557	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00343	0.00547	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00339	0.0054	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00333	0.00531	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00331	0.00528	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.0032	0.00511	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00318	0.00507	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00314	0.005	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00303	0.00483	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00289	0.00461	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00285	0.00455	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00285	0.00454	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00282	0.00451	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00256	0.00409	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00234	0.00374	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00234	0.00373	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00232	0.00371	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—LPL—focal segmental glomerulosclerosis	0.00217	0.00347	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00213	0.0034	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00195	0.00312	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AGT—focal segmental glomerulosclerosis	0.00186	0.00297	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.0018	0.00287	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00179	0.00285	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00152	0.00242	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00147	0.00234	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ALB—focal segmental glomerulosclerosis	0.00143	0.00228	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00139	0.00222	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00126	0.00201	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00116	0.00185	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000967	0.00154	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000741	0.00118	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00061	0.000974	CbGpPWpGaD
